| 04/30/2026 6:02 AM | Redhill Biopharma (1553846) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/27/2026 7:18 AM | Redhill Biopharma (1553846) Filer | Form 20-F Registration statement / Annual report / Transition report | |
| 04/27/2026 7:04 AM | Redhill Biopharma (1553846) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/22/2026 5:09 PM | Raday Gilead (2113137) Reporting Redhill Biopharma (1553846) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 7:02 AM | Redhill Biopharma (1553846) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/14/2026 6:00 AM | Redhill Biopharma (1553846) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/19/2026 6:35 AM | Redhill Biopharma (1553846) Issuer Tsimchi Ofer (2113635) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 12:12 PM | Mamluk Roni (1647053) Reporting Redhill Biopharma (1553846) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 12:12 PM | Raday Gilead (2113137) Reporting Redhill Biopharma (1553846) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 12:14 PM | Redhill Biopharma (1553846) Issuer Reed Kenneth (1569370) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 12:16 PM | Redhill Biopharma (1553846) Issuer Scruggs Rick D (1520801) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for RDHL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Redhill Biopharma and its competitors with MarketBeat's FREE daily newsletter.
|
| 03/18/2026 12:06 PM | Ben-Asher Dror (1568776) Reporting Redhill Biopharma (1553846) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 12:07 PM | Cabilly Shmuel (1569161) Reporting Redhill Biopharma (1553846) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 12:08 PM | Frish Adi (2113141) Reporting Redhill Biopharma (1553846) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 12:09 PM | Goldberg Guy Joel (2113217) Reporting Redhill Biopharma (1553846) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 12:10 PM | Ingber Razi (2113213) Reporting Redhill Biopharma (1553846) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/05/2026 8:00 AM | Redhill Biopharma (1553846) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/25/2026 6:01 AM | Redhill Biopharma (1553846) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/02/2026 6:00 AM | Redhill Biopharma (1553846) Filer | Form 424B3 | |
| 01/27/2026 11:15 PM | Redhill Biopharma (1553846) Filer | Form EFFECT | |
| 01/27/2026 6:00 AM | Redhill Biopharma (1553846) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/22/2026 3:04 PM | Redhill Biopharma (1553846) Filer | Form F-1/A | |
| 01/22/2026 3:06 PM | Redhill Biopharma (1553846) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 01/22/2026 7:56 AM | Redhill Biopharma (1553846) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/05/2026 6:02 AM | Redhill Biopharma (1553846) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/31/2025 4:09 PM | Redhill Biopharma (1553846) Filer | Form F-1 Registration statement for securities of certain foreign private issuers | |
| 12/31/2025 3:58 PM | Redhill Biopharma (1553846) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/23/2025 3:05 PM | Redhill Biopharma (1553846) Subject YA II PN, Ltd. (1463928) Filed by | Form SCHEDULE 13G | |
| 12/23/2025 6:00 AM | Redhill Biopharma (1553846) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/15/2025 6:03 AM | Redhill Biopharma (1553846) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/01/2025 6:02 AM | Redhill Biopharma (1553846) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/04/2025 8:33 AM | Redhill Biopharma (1553846) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/22/2025 3:55 PM | Redhill Biopharma (1553846) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/21/2025 6:00 AM | Redhill Biopharma (1553846) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/21/2025 6:03 AM | Redhill Biopharma (1553846) Filer | Form 424B3 | |
| 10/20/2025 5:48 PM | Alumni Capital LP (1912606) Filed by Redhill Biopharma (1553846) Subject | Form SCHEDULE 13G | |
| 10/20/2025 8:04 AM | Redhill Biopharma (1553846) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/06/2025 7:04 AM | Redhill Biopharma (1553846) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/29/2025 6:04 AM | Redhill Biopharma (1553846) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/09/2025 11:15 PM | Redhill Biopharma (1553846) Filer | Form EFFECT | |
| 09/09/2025 11:15 PM | Redhill Biopharma (1553846) Filer | Form EFFECT | |
|
| 09/05/2025 6:06 AM | Redhill Biopharma (1553846) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/20/2025 8:01 AM | Redhill Biopharma (1553846) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/18/2025 8:03 AM | Redhill Biopharma (1553846) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/14/2025 6:00 AM | Redhill Biopharma (1553846) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/21/2025 8:02 AM | Redhill Biopharma (1553846) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/02/2025 11:15 PM | Redhill Biopharma (1553846) Filer | Form EFFECT | |
| 07/01/2025 11:02 AM | Redhill Biopharma (1553846) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/25/2025 4:24 PM | Redhill Biopharma (1553846) Filer | Form F-1 Registration statement for securities of certain foreign private issuers | |
| 06/25/2025 4:04 PM | Redhill Biopharma (1553846) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/27/2025 6:00 AM | Redhill Biopharma (1553846) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/13/2025 6:04 AM | Redhill Biopharma (1553846) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/05/2025 7:04 AM | Redhill Biopharma (1553846) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |